Daniel Lochner bought $130k of TECX
Chief Financial Officer at Tectonic Therapeutic, Inc.. 6,000 shares at an average of $21.61, traded Feb 10, 2026, filed Feb 11, 2026.
Score components
- +22RoleCFO
- +11Trade size$130k at market
- +6Relative to holdingsHoldings up 23%
- +8Price context41% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +51.3%, 3m +30.9%, 6m +67.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001791187-26-000003, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | POpen-market purchase Common Stock | +6,000 | $21.61 | $130k | 32,044 | Feb 11, 2026 |
Related signals
Other insiders at Tectonic Therapeutic, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $12k 536 shares | -1% | |
| 0Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $1,570 43 shares | -0% | |
| 0Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $1,505 43 shares | -0% | |
| 0Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $6,020 172 shares | -0% | |
| 0Weak | Tectonic Therapeutic, Inc. | Marcella K. Ruddy Chief Medical Officer | $32k 1,065 shares | -2% | |
| 0Weak | Tectonic Therapeutic, Inc. | Marcella K. Ruddy Chief Medical Officer | $31k 1,000 shares | -1% | |
| 5Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $189k 6,262 shares | -10% | |
| 22Weak | Tectonic Therapeutic, Inc. | Marcella K. Ruddy Chief Medical Officer | $300k 10,000 shares | -13% | |
| 12Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $78k 3,299 shares | -8% | |
| 48Moderate | Tectonic Therapeutic, Inc. | Alise Reicin Chief Executive Officer | $53k 2,500 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.